- Home
- HUYA vs PSNL Comparison
HUYA vs PSNL Comparison
Compare HUYA & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HUYA | PSNL |
|---|---|---|
| Founded | 2014 | 2011 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 773.0M | 729.1M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | HUYA | PSNL |
|---|---|---|
| Price | $3.22 | $5.91 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $3.50 | ★ $12.20 |
| AVG Volume (30 Days) | 605.0K | ★ 1.8M |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | ★ 81.37% | N/A |
| EPS Growth | N/A | ★ 33.58 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $69,648,000.00 |
| Revenue This Year | $14.08 | $15.34 |
| Revenue Next Year | $6.11 | $41.46 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.21 | $3.84 |
| 52 Week High | $4.93 | $11.50 |
Technical Indicators
Market Signals| Indicator | HUYA | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 50.11 | 43.29 |
| Support Level | $3.10 | $5.81 |
| Resistance Level | $3.36 | $6.99 |
| Average True Range (ATR) | 0.10 | 0.43 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 58.21 | 43.17 |
Price Performance
Historical ComparisonAbout HUYA HUYA Inc. American depositary shares each representing one ordinary share
Huya, officially became independent in 2016 and headquartered in Guangzhou, operates live streaming platform focused on games, esports, and interactive entertainment, and also provides game-related services such as distribution and in-game item sales. Its main livestreaming platforms include Huya Live in China and Nimo TV outside of China. As of 2024, Huya was a subsidiary of Tencent, which owned 67% of its equity stake and held 95% of the voting power.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.